ICD-10 Code B44.1 | Other pulmonary aspergillosis Symptoms, Diagnosis, Billing

Other pulmonary aspergillosis is a fungal infection caused by various species of Aspergillus, which can lead to significant respiratory complications. This condition is particularly important for accurate diagnosis and documentation, as it can affect treatment decisions and patient outcomes. The ICD-10 Code B44.1 facilitates precise medical billing and public health reporting, ensuring that healthcare providers can track and manage cases effectively.

What is ICD-10 Code B44.1 for Other pulmonary aspergillosis?

ICD-10 Code B44.1 represents Other pulmonary aspergillosis, a condition characterized by the presence of Aspergillus species in the lungs, leading to respiratory symptoms and potential complications. This code should be used when documenting cases that do not fit into more specific categories of pulmonary aspergillosis, ensuring accurate clinical documentation and appropriate billing practices.

ICD-10 Code B44.1 – Clinical Definition and Explanation of Other pulmonary aspergillosis

Other pulmonary aspergillosis is caused by inhalation of Aspergillus spores, which can lead to various pulmonary manifestations, particularly in immunocompromised individuals. The condition may progress to severe respiratory distress if not treated promptly, necessitating medical intervention.

Key Clinical Features:

• Chronic cough, often productive of sputum
• Hemoptysis (coughing up blood)
• Chest pain or discomfort
• Wheezing or shortness of breath

ICD-10 Code B44.1 for Other pulmonary aspergillosis – SOAP Notes & Clinical Use

ICD-10 Code B44.1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and guiding clinical decision-making.

What Does ICD-10 Code B44.1 for Other pulmonary aspergillosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B44.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Other pulmonary aspergillosis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B44.1 – Other pulmonary aspergillosis

Other pulmonary aspergillosis requires prompt medical attention, particularly in immunocompromised patients. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

• Voriconazole: First-line treatment, typically for 6-12 weeks.
• Amphotericin B: Alternative for severe cases, duration varies based on response.
• Posaconazole: Considered for refractory cases.

Supportive Care:

• Oxygen therapy to manage hypoxemia.
• Bronchodilators to relieve wheezing.
• Corticosteroids may be used to reduce inflammation.

Infection Control:

• Implement isolation precautions for immunocompromised patients.
• Educate patients on avoiding exposure to mold and dust.
• Monitor for outbreaks in healthcare settings.

How to Document Symptoms of Other pulmonary aspergillosis (ICD-10 B44.1) in SOAP Notes

Subjective:

• Patient reports persistent cough with greenish sputum.
• History of hemoptysis noted over the past week.
• Complaints of chest pain, especially during deep breaths.
• Shortness of breath worsens with exertion.

Objective:

• Wheezing noted on auscultation.
• Respiratory rate: 24 breaths per minute.
• Oxygen saturation: 92% on room air.
• Chest X-ray shows infiltrates consistent with fungal infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Other pulmonary aspergillosis (ICD-10 Code B44.1)

Assessment:

• Diagnosis: Other pulmonary aspergillosis, moderate severity.
• ICD-10 Code: B44.1.
• Contributing factors: Recent history of immunosuppression.
• Triggers: Exposure to moldy environments.

Plan:

• Initiate voriconazole therapy, monitor for side effects.
• Educate patient on recognizing worsening symptoms.
• Schedule follow-up in 2 weeks for reassessment.
• Consider pulmonary function tests to evaluate lung function.

Treatment & Plan Section for ICD-10 Code B44.1 – Other pulmonary aspergillosis

• First-line pharmacologic treatment includes voriconazole.
• Non-pharmacologic strategies involve patient education on mold avoidance.
• Monitoring includes regular assessment of respiratory status and oxygen levels.
• Follow-up practices should include repeat imaging to assess treatment response.

Using ICD-10 Code B44.1 for Other pulmonary aspergillosis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Ensure Subjective (S) and Objective (O) sections clearly reflect the patient's symptoms and clinical status.
• Align treatment plans with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond to the services provided.

Related ICD-10 Codes Often Used with Other pulmonary aspergillosis

• B44.0 – Aspergillosis, unspecified
• B44.9 – Aspergillosis, unspecified

ICD-10 Code B44.1 in Medical Billing and Insurance for Other pulmonary aspergillosis

ICD-10 Code B44.1 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of this code.
• Use this code in conjunction with other relevant codes for comprehensive billing.
• Ensure that the diagnosis is clearly linked to the patient's presenting symptoms.
• Review payer guidelines for specific documentation requirements.

Common CPT Pairings: